期刊文献+

多发性骨髓瘤干细胞研究进展

Research advancement on multiple myeloma stem cells
原文传递
导出
摘要 肿瘤干细胞具有高度增殖与自我更新及多向分化的潜能,与肿瘤的复发和难以根治密切相关。在多发性骨髓瘤中亦存在这样一小部分骨髓瘤干细胞,积极探索其起源、免疫分型、信号转导机制、耐药性及其他生物学特性对多发性骨髓瘤的根治有重要意义。 Tumor stem cells have abilities of high proliferation, self-renewal and multi-directional differentiation,which is closely responsible for tumor' s survival and recurrence. A minor portion of myeloma stem cells exist in multiple myeloma. The research of myeloma stem cells' origins, phenotypic analyses, signaling pathways, drug resistance and other biological characteristics will do great efforts to the effective therapy of multiple myeloma.
出处 《国际肿瘤学杂志》 CAS 2009年第8期629-631,共3页 Journal of International Oncology
关键词 多发性骨髓瘤 干细胞 治疗 Multiple myeloma Stem cells Therapy
  • 相关文献

参考文献17

  • 1Dalerba P, Dylla SJ, Park IK, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Nat Acad Sci USA, 2007, 104(24) :10158-10163.
  • 2Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumor initiating cells. Nature, 2004, 432 (7015 ) :396-401.
  • 3Ghosh N, Matsui W. Cancer stem cells in multiple myeloma. Cancer Lett, 2009, 277 ( 1 ) : 1-7.
  • 4Matsui W, Huff CA, Wang Q, et al. Characterization of clonogenic muhiplemyeloma cells. Blood, 2004, 103(6) :2332-2336.
  • 5Matsui W, Wang Q, Barber JP, et al. Clonogenie multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Res,2008, 68( 1 ) :190-197.
  • 6Guo W, Lasky JL 3rd, Wu H. Cancer stem cells. Pediatr Res, 2006, 59(4 Pt 2) :59R-64R.
  • 7Luckey CJ, Bhattacharya D, Goldrath AW, et al. Memory T and memory B ceils share a transcriptional program of self-renewal with long-term hematopoietic stem cells. Proc Nad Acad Sci USA, 2006, 103(9) :3304-3309.
  • 8Tomayko MM, Anderson SM, Brayton CE, et al. Systematic comparison of gene expression between murine memory and naive B ceils demonstrates that memory B cells have unique signaling capabili6ties. J Immunol, 2008, 181 ( 1 ) :27-38.
  • 9Yaccoby S. The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient, and apopto- sis-resistant phenotype. Clin Cancer Res, 2005, 11 (21) :7599- 7606.
  • 10Schmidmaier R, Simsek M, Batimann P, et al. Synergistic antimyeloma effects of zoledronate and simvastatin. Anticancer Drugs, 2006, 17(6) :621-629.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部